Skip to main content
Professional Technical IVT

gene therapy

A therapeutic approach involving introduction of genetic material to correct defective genes causing immunodeficiency diseases.

Full Definition

An emerging treatment modality for primary immunodeficiencies that involves introducing functional genes into a patient's cells to correct underlying genetic defects. Current approaches include ex vivo gene therapy, where the patient's own stem cells are modified with viral vectors containing the normal gene and then reinfused, and in vivo gene editing techniques. Gene therapy has shown particular success in treating severe combined immunodeficiency caused by adenosine deaminase deficiency and X-linked SCID. The field continues to evolve with advances in vector design and gene editing technologies, offering hope for treating previously incurable immunodeficiencies without the need for matched donors.

Usage

Usage note: Distinguish from gene editing; emphasize therapeutic application in immunodeficiency contexts.

In Context

  • "Gene therapy protocols offered an alternative to bone marrow transplantation for patients lacking suitable donors." — Clinical trial documentation
  • "Long-term follow-up after gene therapy demonstrated sustained immune reconstitution without adverse events." — Research outcome report

Also known as

genetic therapy gene transfer therapy gene correction

Contrasted with

conventional therapy pharmacological treatment

Don't confuse with

gene editing cell therapy regenerative medicine

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON